iDC processed by a PKC inhibitor possessed augmented expression of CCR7 and migration rate to lymph nodes, which will activate functional Tregs greatly and show satisfactory tolerance-inducing effect for rheumatoid arthritis and primary Sjögren’s syndrome (Adnan et al., 2016). This evidence concerns the gene CCR7 and rheumatoid arthritis.